Evogene share price logo

Evogene

NASDAQ: EVGN

$0.31

-0.04

(-11.14%)

Live

as on

Evogene Stock Performance

as on November 20, 2026 at 4:25 am IST

  • Day's Low

    Day's High

    $0.30
    $0.34
    downward going graph

    3.54%

    Downside

    9.32%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.25
    $1.26
    downward going graph

    19.52%

    Downside

    305.14%

    Upside

    downward going graph

Evogene share price movements today

Previous Close
$0.35
Open
$0.32
Volume
210.0K
Market Cap
$6.2M
Day's Low - High
$0.30 - $0.34
52 Week Low - High
$0.25 - $1.26

Evogene Historical Returns

1 Month Return
-4.89 %
3 Month Return
-41.75 %
1 Year Return
-70.09 %
3 Year Return
-94.7 %
5 Year Return
-98.36 %

Evogene Stock Fundamentals & Key Indicators

Check Evogene market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.2M

EPS (TTM)

-0.91

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.41

Industry PE ratio

-2.83

PEG Ratio

0.00

EBITDA

-12.6M

Revenue (TTM)

1.3M

Profit Margin

-14.16%

Return On Equity TTM

761.97%

Evogene vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Evogene with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$6.2M-98.36%-0.41-14.16%0.00%
Neutral$83.7B-25.40%-29.1428.00%0.00%
StrongBuy$47.2BNA65.7688.39%0.00%
StrongBuy$135.4B193.33%34.1185.53%0.00%
Buy$99.1B44.87%20.2985.77%0.39%

Stock Returns calculator for Evogene Stock including INR - Dollar returns

The Evogene stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Evogene investment value today

Current value as on today

₹28,023

Returns

-₹71,977

(-71.98%)

Returns from Evogene Stock

-₹73,419 (-73.42%)

Dollar Impact

₹1,441 (+1.44%)

Analyst Recommendation on Evogene Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Evogene. Average target price of $2.15

Evogene Share Price Target

Get share price movements and forecasts by analysts on Evogene.

What analysts predicted

85.53%UPSIDE

Target Price

$2.15

Current Price

$0.311

Analyzed by

8 Analysts

Target

$2.15

Evogene target price $2.15, a slight upside of 85.53% compared to current price of $0.311. According to 8 analysts rating.

Indian Investors' Interest in Evogene Stock

Search interest for Evogene Stock has decreased by -86% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-86% versus previous 30 day period

Evogene Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
4
0
1
1
2
0
0
0
0
0
Gross Profit
3
0
0
0
0
0
0
-1
0
0
Operating Income
-4
-4
-5
-4
-4
-3
-2
-5
-3
-2
EBITDA
-3
-4
-3
-2
-1
-2
-1
-6
-1
-2
Interest Expense
0
0
2
0
0
0
0
0
3
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-4
-6
0
-2
-3
-2
-5
-5
-1
Income Tax Expense
-
0
0
0
-
0
0
-
0
-
Net Income
-3
-5
-7
0
-2
-4
3
-5
-5
-1
Net Profit Margin
76.59%
-10.08%
28.10%
53.13%
33.96%
84.62%
49.68%
-627.39%
61.08%
-2.31%

Evogene Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
3
1
0
1
0
1
2
5
3
Gross Profit
0
0
0
0
0
0
1
3
0
Operating Income
-21
-19
-21
-24
-30
-26
-22
-18
-14
EBITDA
-18
-18
-16
-23
-27
-27
-20
-13
-12
Interest Expense
0
0
0
0
0
0
0
0
1
Depreciation
2
2
2
2
2
2
1
1
1
Income Before Tax
-20
-20
-19
-26
-30
-29
-21
-14
-13
Income Tax Expense
0
0
0
0
0
0
0
0
0
Net Income
-20
-20
-18
-23
-27
-26
-23
-16
-8
Net Profit Margin
-38.45%
-89.52%
-312.08%
-217.40%
-222.69%
-105.91%
24.80%
57.32%
-6.25%

Evogene Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-4
-8
0
-2
-2
-4
-5
-5
-1
Operating Cash Flow
-4
-5
-4
-5
-5
-2
-3
-2
-2
-2
Investing Cash Flow
-4
3
2
8
-2
-1
11
10
-4
4
Financing Cash Flow
0
0
4
0
0
4
-10
0
2
-1
Change in Cash
-8
-2
1
3
-7
0
-2
7
-4
0

Evogene Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-20
-20
-19
-26
-30
-29
-25
-18
-14
Operating Cash Flow
-15
-15
-17
-19
-24
-23
-21
-19
-13
Investing Cash Flow
15
17
37
9
-20
13
-4
9
17
Financing Cash Flow
0
0
9
20
30
9
18
4
-6
Change in Cash
0
2
28
11
-13
-3
-8
-5
-2

Global Institutional Holdings in Evogene

Check out the Institutions with significant holdings in Evogene.

Funds
Holdings
Shares Held
LEON RECANATI
7.44%
1343886
Tachlit
0.46%
83086
KSM
0.28%
50116
Gabi Tarcic
0.01%
1129

Evogene News & Key Events

  • img

    Today's Timeline - 19 November

    Thu, 08:08 PM

    -

    Evogene announces board chair appointment and VP Finance change amid ongoing financial struggles.

    Thu, 08:11 PM

    -

    Evogene reports Q3 results; revenue declines to $0.8 million, net loss rises to $10.5 million.

Insights on Evogene

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 4 quarters, 312.0K → 347.0K (in $), with an average increase of 3.5% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -5.87M → -1.76M (in $), with an average increase of 232.0% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 713.9% return, outperforming this stock by 784.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 157.4% return, outperforming this stock by 252.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, EVGN stock has moved down by -94.7%

About Evogene

Evogene Ltd. is a computational biology firm specializing in the identification and advancement of products across human health and agricultural sectors. Its proprietary Computational Predictive Biology (CPB) platform leverages deep biological insights, big data, and artificial intelligence to precisely uncover and guide the creation of life science solutions, including novel microbes, small molecules, and genetic components. The company operates through distinct divisions: Agriculture, Human Health, and Industrial Applications. The Agriculture division concentrates on improving crop performance through the development of advanced seed traits, agricultural chemicals, and biological products for crops like corn, soybean, wheat, rice, and cotton. The Human Health division focuses on pioneering microbiome-based treatments for conditions such as immuno-oncology, gastrointestinal ailments, and antibiotic-resistant infections, and also offers medical cannabis products. The Industrial Applications segment is dedicated to developing improved castor bean varieties for various industrial feedstock requirements. Evogene has a global footprint, conducting business in the United States, Israel, Brazil, and other international markets. It maintains significant partnerships, including agricultural collaborations with BASF SE, Corteva, and Bayer, and a medical cannabis development agreement with Cannbit Ltd. through its subsidiary, Canonic Ltd. Established in 1999, Evogene Ltd. is headquartered in Rehovot, Israel.
OrganisationEvogene
Headquarters13 Gad Feinstein Street, Rehovot, HM, 7638517, IL
IndustryBiotechnology
CEOOfer Haviv

Key Management of Evogene

Name

Title

Dr. Dan Jacob Gelvan Ph.D.

Chief Executive Officer of Ag Plenus Ltd.

Dr. Ilia Zhidkov

Chief Technology Officer

Ms. Liat Foigel Wejgman

Vice President of Human Resources

Dr. Gabi Tarcic Ph.D.

Chief Development Officer

Mr. Ofer Haviv CPA

CEO, President, CFO & Director

Mr. Yoash Zohar

Chief Executive Officer of Casterra Ag Ltd.

FAQs

What is Evogene share price today?

Evogene share price today is $0.31 as on . Evogene share today touched a day high of $0.34 and a low of $0.30.

What is the 52 week high and 52 week low for Evogene share?

Evogene share touched a 52 week high of $1.26 on and a 52 week low of $0.25 on . Evogene stock price today i.e. is trending at $0.31,which is 75.32% down from its 52 week high and 24.25% up from its 52 week low.

What is Evogene's market capitalisation today?

Evogene market capitalisation is $0.00T as on .

How to invest in Evogene Stock (EVGN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Evogene on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Evogene Stock (EVGN) from India?

Indian investors can start investing in Evogene (EVGN) shares with as little as ₹93.29000091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.90 in Evogene stock (as per the Rupee-Dollar exchange rate as on ). Based on Evogene share’s latest price of $0.31 as on November 19, 2026 at 10:55 pm IST, you will get 32.1543 shares of Evogene. Learn more about fractional shares .

What are the returns that Evogene has given to Indian investors in the last 5 years?

Evogene stock has given -98.36% share price returns and 26.33% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?